Celldex (CLDX) Tops Q4 EPS by 4c

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.97 million versus the consensus estimate of $1.08 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Cracker Barrel (CBRL) Tops Q3 EPS by 71c